NCT04703192 · Interventional trial
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Overall registry status Active not recruiting
Phase 2
Conditions Adult T Cell Leukemia/Lymphoma, Relapsed/Refractory Peripheral T-Cell Lymphoma
Delaware Valley sites
- University of Pennsylvania Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory